⚠ Evidence note: An aging clock is a statistical model, not a measurement of aging itself; predictive validity varies widely between clocks and populations.
Transcriptomic Entropy as Tissue-Level Aging Metric
Current understanding
Tissue-level transcriptomic entropy quantifies disorder in gene expression distributions and has been proposed as an organ-specific aging readout that also tracks cancer progression [human-observational]. Distinct from regression-trained transcriptomic clocks like LivAge, it is a model-free information-theoretic metric, so its predictive validity across tissues and outcomes still needs independent replication.
Evidence log
- 2026-09-22 — Tissue-specific aging clocks map structured aging-modulatory drug-score patterns across 49 human tissue and cell-line categories.: cross-connection with transcriptomic-aging-clocks: Both are tissue-resolved RNA-seq aging readouts across human tissues; the GTEx-based 49-category clock panel and transcriptomic entropy are complementary organ-specific views of the same substrate and disagree in construction (trained regression vs model-free disorder). (novelty: 3)
- 2026-09-04 — Tissue‐Level Transcriptomic Entropy Reveals Organ‐Specific Aging Patterns and Predicts Cancer Progression: cross-connection with transcriptomic-aging-clocks: Both derive from RNA-seq data but differ methodologically: entropy is a model-free disorder metric per tissue, while LivAge-style clocks are trained regressors — open question whether entropy adds signal beyond expression-trained clocks. (novelty: 3)
Open questions
Related
Contributing findings
Tissue‐Level Transcriptomic Entropy Reveals Organ‐Specific Aging Patterns and Predicts Cancer Progression
04-sep-2026
novelty 3
per-area 3
introduces